Successful transition to tenofovir/lamivudine/dolutegravir (TLD) in PEPFAR-supported countriesJ. da Silva, S. Vallabhaneni, R. Pati, H. Chun, C. Malati, D. Kiesa, J. Rosenfield, M. Belayneh,K. Fisher, G. Siberry, E. Raizes, C. GodfreyJOURNAL OF THE INTERNATIONAL AIDS SOCIETY(2022)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要